DCTY1102
/ Beijing DCTY Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 11, 2025
A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=110 | Not yet recruiting | Sponsor: Beijing DCTY Biotech Co.,Ltd.
New P1 trial • Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • KRAS
1 to 1
Of
1
Go to page
1